D'Haese, J. G. Et Al. 2010. Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential. EXPERT OPINION ON THERAPEUTIC TARGETS , vol.14, no.2 , 207-219.

D'Haese, J. G., Demir, I. E., Friess, H., & Ceyhan, G., (2010). Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential. EXPERT OPINION ON THERAPEUTIC TARGETS , vol.14, no.2, 207-219.

D'Haese, Jan Et Al. "Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential," EXPERT OPINION ON THERAPEUTIC TARGETS , vol.14, no.2, 207-219, 2010

D'Haese, Jan G. Et Al. "Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential." EXPERT OPINION ON THERAPEUTIC TARGETS , vol.14, no.2, pp.207-219, 2010

D'Haese, J. G. Et Al. (2010) . "Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential." EXPERT OPINION ON THERAPEUTIC TARGETS , vol.14, no.2, pp.207-219.

@article{article, author={Jan G. D'Haese Et Al. }, title={Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential}, journal={EXPERT OPINION ON THERAPEUTIC TARGETS}, year=2010, pages={207-219} }